Cargando…

Optimization of 2-Aminoquinazolin-4-(3H)-one Derivatives as Potent Inhibitors of SARS-CoV-2: Improved Synthesis and Pharmacokinetic Properties

We previously reported the potent antiviral effect of the 2-aminoquinazolin-4-(3H)-one 1, which shows significant activity (IC(50) = 0.23 μM) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with no cytotoxicity. However, it is necessary to improve the in vivo pharmacokinetics of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Young Sup, Lee, Jun Young, Jeon, Sangeun, Cho, Jung-Eun, Myung, Subeen, Jang, Min Seong, Kim, Seungtaek, Song, Jong Hwan, Kim, Hyoung Rae, Park, Hyeung-geun, Jeong, Lak Shin, Park, Chul Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318802/ https://www.ncbi.nlm.nih.gov/pubmed/35890130 http://dx.doi.org/10.3390/ph15070831

Ejemplares similares

Discovery of 2-aminoquinolone acid derivatives as potent inhibitors of SARS-CoV-2
por: Shin, Young Sup, et al.
Publicado: (2023)

Design, synthesis and biological evaluation of 2-aminoquinazolin-4(3H)-one derivatives as potential SARS-CoV-2 and MERS-CoV treatments
por: Lee, Jun Young, et al.
Publicado: (2021)

Identification of 4-anilino-6-aminoquinazoline derivatives as potential MERS-CoV inhibitors
por: Lee, Jun Young, et al.
Publicado: (2020)

Discovery of cyclic sulfonamide derivatives as potent inhibitors of SARS-CoV-2
por: Shin, Young Sup, et al.
Publicado: (2021)

Synthesis and biological evaluation of 3-acyl-2-phenylamino-1,4-dihydroquinolin-4(1H)-one derivatives as potential MERS-CoV inhibitors
por: Yoon, Ji Hye, et al.
Publicado: (2019)

Anticoronaviral Activity of the Natural Phloroglucinols, Dryocrassin ABBA and Filixic Acid ABA from the Rhizome of Dryopteris crassirhizoma by Targeting the Main Protease of SARS-CoV-2
por: Jin, Young-Hee, et al.
Publicado: (2022)

Broad Spectrum Antiviral Properties of Cardiotonic Steroids Used as Potential Therapeutics for Emerging Coronavirus Infections
por: Jin, Young-Hee, et al.
Publicado: (2021)

Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections
por: Jin, Young-Hee, et al.
Publicado: (2021)

Natural Bis-Benzylisoquinoline Alkaloids-Tetrandrine, Fangchinoline, and Cepharanthine, Inhibit Human Coronavirus OC43 Infection of MRC-5 Human Lung Cells
por: Kim, Dong Eon, et al.
Publicado: (2019)

Identification of 6′-β-fluoro-homoaristeromycin as a potent inhibitor of chikungunya virus replication
por: Shin, Young Sup, et al.
Publicado: (2020)

Crystal structures of 6-nitroquinazolin-4(3H)-one, 6-aminoquinazolin-4(3H)-one and 4-aminoquinazoline hemihydrochloride dihydrate
por: Turgunov, Kambarali, et al.
Publicado: (2021)

Natural Polyphenols, 1,2,3,4,6-O-Pentagalloyglucose and Proanthocyanidins, as Broad-Spectrum Anticoronaviral Inhibitors Targeting Mpro and RdRp of SARS-CoV-2
por: Jin, Young-Hee, et al.
Publicado: (2022)

Pharmacokinetic properties and bioequivalence of gefitinib 250 mg in healthy Korean male subjects
por: Moon, Seol Ju, et al.
Publicado: (2021)

Synthesis, Biological Evaluation and Molecular Docking of Novel Indole-Aminoquinazoline Hybrids for Anticancer Properties
por: Mphahlele, Malose J., et al.
Publicado: (2018)

Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
por: Jeon, Sangeun, et al.
Publicado: (2020)

Identification of 3-Oxindole Derivatives as Small Molecule HIV-1 Inhibitors Targeting Tat-Mediated Viral Transcription
por: Kim, Dong-Eun, et al.
Publicado: (2022)

Collaborative Virtual Screening Identifies a 2-Aryl-4-aminoquinazoline Series with Efficacy in an In Vivo Model of Trypanosoma cruzi Infection
por: Tawaraishi, Taisuke, et al.
Publicado: (2023)

Sonic Hedgehog Pathway as the Prognostic Marker in Patients with Extensive Stage Small Cell Lung Cancer
por: Lim, Seungtaek, et al.
Publicado: (2019)

Utility of a Hydrolysate from Overproduced Paralichthys olivaceus for Hypertension Treatment: Correlation between Physical Properties and Potent Anti-Hypertensive Activities
por: Lee, Hyo-Geun, et al.
Publicado: (2022)

An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus
por: Kim, Ki Hyun, et al.
Publicado: (2019)

Synthesis and structure–activity relationship study of saponin-based membrane fusion inhibitors against SARS-CoV-2
por: Jang, Youngho, et al.
Publicado: (2022)

Lancemaside A from Codonopsis lanceolata: Studies on Antiviral Activity and Mechanism of Action against SARS-CoV-2 and Its Variants of Concern
por: Kim, Tai Young, et al.
Publicado: (2022)

Overexpression of Prohibitin 2 Protein is Associated with Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia
por: Lee, Young Eun, et al.
Publicado: (2022)

In Vitro, In Silico, and In Vivo Assessments of Pharmacokinetic Properties of ZM241385
por: Byeon, Jin-Ju, et al.
Publicado: (2020)

In vivo tissue pharmacokinetics of ERBB2‐specific binding oligonucleotide‐based drugs by PET imaging
por: Park, Sun Mi, et al.
Publicado: (2023)

Quantitative Analysis of Tozadenant Using Liquid Chromatography-Mass Spectrometric Method in Rat Plasma and Its Human Pharmacokinetics Prediction Using Physiologically Based Pharmacokinetic Modeling
por: Lee, Byeong ill, et al.
Publicado: (2019)

Astersaponin I from Aster koraiensis is a natural viral fusion blocker that inhibits the infection of SARS-CoV-2 variants and syncytium formation
por: Kim, Tai Young, et al.
Publicado: (2022)

Synthesis of chiral malonates by α-alkylation of 2,2-diphenylethyl tert-butyl malonates via enantioselective phase-transfer catalysis
por: Guo, Zhibin, et al.
Publicado: (2023)

Phloretin as a Potent Natural TLR2/1 Inhibitor Suppresses TLR2-Induced Inflammation
por: Kim, Jieun, et al.
Publicado: (2018)

Physicochemical, Pharmacokinetic, and Toxicity Evaluation of Soluplus(®) Polymeric Micelles Encapsulating Fenbendazole
por: Jin, Ik Sup, et al.
Publicado: (2020)

Unguided De-Escalation Strategy From Potent P2Y(12) Inhibitors in Patients Presented With ACS: When, Whom and How?
por: Park, Jin Sup, et al.
Publicado: (2022)

6′-β-Fluoro-Homoaristeromycin and 6′-Fluoro-Homoneplanocin A Are Potent Inhibitors of Chikungunya Virus Replication through Their Direct Effect on Viral Nonstructural Protein 1
por: Kovacikova, Kristina, et al.
Publicado: (2020)

Additive anti-allergic effects of anti-interleukin-33 and anti-Siglec-F treatments in a murine model of allergic asthma
por: Jang, Tae Young, et al.
Publicado: (2014)

Anti-inflammatory effects of sargachromenol-rich ethanolic extract of Myagropsis myagroides on lipopolysaccharide-stimulated BV-2 cells
por: Kim, Sunghee, et al.
Publicado: (2014)

Benzofuran–appended 4-aminoquinazoline hybrids as epidermal growth factor receptor tyrosine kinase inhibitors: synthesis, biological evaluation and molecular docking studies
por: Mphahlele, Malose J., et al.
Publicado: (2018)

Phosphatase CDC25B Inhibitors Produced by Basic Alumina-Supported One-Pot Gram-Scale Synthesis of Fluorinated 2-Alkylthio-4-aminoquinazolines Using Microwave Irradiation
por: Liu, Jin, et al.
Publicado: (2018)

ECG-ViEW II, a freely accessible electrocardiogram database
por: Kim, Young-Gun, et al.
Publicado: (2017)

Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay
por: Jang, Woo Dae, et al.
Publicado: (2021)

Optimization and Pharmacokinetic Evaluation of Synergistic Fenbendazole and Rapamycin Co-Encapsulated in Methoxy Poly(Ethylene Glycol)-b-Poly(Caprolactone) Polymeric Micelles
por: Shin, Hee Ji, et al.
Publicado: (2021)

Design, synthesis, and biological evaluation of novel iso-d-2′,3′-dideoxy-3′-fluorothianucleoside derivatives
por: Kim, Kyung Ran, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_s388m7t1u03agf58bum23uid90